Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-24 @ 11:33 PM
NCT ID:
NCT03407456
Eligibility Criteria:
Inclusion Criteria:
* Males and non-pregnant females over the age of 18 years.
* Gastro-oesophageal symptoms in accordance with Montreal criteria#
* Patients with clinical indications for Bravo™, including:
* symptomatic patients with non-diagnostic endoscopy and catheter-based pH tests
* preoperative evaluation before antireflux procedures
* persistent or recurrent post-operative symptoms
* Participants need to understand spoken and written English
* Patients must sign an informed consent form.
Exclusion Criteria:
* Contraindications to endoscopy
* Known allergy or intolerance to PPI
* History of bleeding diathesis or coagulopathy
* Chronic liver disease, oesophageal varices
* Pregnancy
* Any medical or non-medical condition that in the opinion of the research team will make the candidate unfit for this study, such as heart failure and drug abuse.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03407456
Study Brief:
Protocol Section:
NCT03407456